Sriram Naganathan
Vice President, Technical Operations, Drug Substance @Revolution Medicines
Signup · Get unlimited contacts
WORK HISTORY
Vice President, Technical Operations, Drug Substance @Revolution Medicines
EDUCATION
University at Albany
Ph.D., Organic Chemistry (Organosulfur)
The University of Kansas
MS, Organic Chemistry
Vivekananda College (University of Madras), India
Bachelor of Science (B.Sc.), Chemistry
SKILLS
ABOUT SRIRAM NAGANATHAN
Accomplished drug development and CMC professional offering over 28 years of experience advancing programs from preclinical development through commercialization of small molecules and peptides. Hands-on experience in multi-step synthesis, route-scouting, process development, scale-up, tech transfer to CRO/CMO, including manufacture under cGMP and process validation. Broad experience in managing outsourced production of drug substance, drug product, analytical development. Working knowledge of biologics development. Extensive knowledge of CMC regulatory landscape (FDA, EMEA) including preparation of CMC sections of IND, IMPD, NDA and MAA and interacting with Regulatory AgenciesKey member of drug substance team of three approved therapeutics: cabozantinib (Cometriq; Cabometyx - preclinical through commercialization), cobimetinib (Cotellic - preclinical through PhI) and glycopyrronium (Qbrexza - drug substance lead for Phase through commercialization)Recruited and built scalable CMC Organization
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.